Trials / Completed
CompletedNCT05749861
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)
A Phase I Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348(5) Compared With Co-administration of CKD-828, D097, and D337 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
A phase I clinical trial to evaluate the tolerability and the pharmacokinetics of CKD-348(5).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-348(5) | QD, PO |
| DRUG | CKD-828, D097, D337 | QD, PO |
Timeline
- Start date
- 2023-04-22
- Primary completion
- 2023-06-07
- Completion
- 2023-07-18
- First posted
- 2023-03-01
- Last updated
- 2024-01-23
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05749861. Inclusion in this directory is not an endorsement.